ADL5747

DRUG2 trials

Sponsors

Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

Conditions

Osteoarthritis of the KneePostherpetic Neuralgia

Phase 2

Efficacy and Safety Study Evaluating ADL5859 and ADL5747 in Participants With Pain Due to Osteoarthritis of the Knee

CompletedNCT00979953

Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)Osteoarthritis of the Knee

Start: 2009-10-31End: 2010-06-30Updated: 2015-08-14

Study to Assess the Efficacy, Safety, and Tolerability of ADL5747 in Participants With Postherpetic Neuralgia

TerminatedNCT01058642

Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)Postherpetic Neuralgia

Start: 2010-01-31End: 2010-12-31Updated: 2015-07-30